Sajdel-Sulkowska EM, Lipinski B, Windom H, Audhya T, McGinnis W
However, these studies are observational, not randomized trials, so we cannot yet interpret the findings as proof of a cancer risk reduction. The review also addressed the question of whether GLP-1s reduce cancer risk because they cause weight loss and improved metabolism, or because they have a direct anti-cancer effect
Effects of GSTM2 on LD content do not absolutely depend on regulating ROS level Because GSTM2 has antioxidant activity (as described in the Introduction), the potential effect of ROS on cellular lipid formation should be examined
I took some other drops for 4-months that did nothing
Shabnam Sarshar, MBA phytopharmacist, PhD in pharmaceutical biology, certified in endocannabinoid medicine
The error bars in (B) and (D) represent the standard errors of the kobs values estimated separately at each inhibitor concentration, as obtained from nonlinear regression analysis